TransCode Therapeutics, Inc.
RNAZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,856 | -$4,277 | -$12,085 | -$5,916 |
| Dep. & Amort. | $5 | $13 | $51 | $123 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $158 | $169 |
| Change in WC | $355 | -$225 | -$455 | $942 |
| Other Non-Cash | $413 | $293 | $9,234 | $1,536 |
| Operating Cash Flow | -$4,083 | -$4,194 | -$3,097 | -$3,146 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $8,855 | $7,082 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$456 | $0 | $0 | $0 |
| Financing Cash Flow | -$456 | $0 | $8,855 | $7,082 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$4,539 | -$4,194 | $5,758 | $3,935 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,375 | $11,569 | $5,811 | $1,876 |
| End Cash | $2,836 | $7,375 | $11,569 | $5,811 |
| Free Cash Flow | -$4,083 | -$4,194 | -$3,097 | -$3,147 |